BIOMAT Database Logo BIOMAT Database Logo

Testing of blood donations for hepatitis C virus. 1994

B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds

UI MeSH Term Description Entries
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012698 Serologic Tests Diagnostic procedures involving immunoglobulin reactions. Serodiagnosis,Serologic Test,Serological Tests,Test, Serologic,Tests, Serologic,Serodiagnoses,Serological Test,Test, Serological,Tests, Serological
D015151 Immunoblotting Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies. Dot Immunoblotting,Electroimmunoblotting,Immunoelectroblotting,Reverse Immunoblotting,Immunoblotting, Dot,Immunoblotting, Reverse,Dot Immunoblottings,Electroimmunoblottings,Immunoblottings,Immunoblottings, Dot,Immunoblottings, Reverse,Immunoelectroblottings,Reverse Immunoblottings
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus

Related Publications

B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Screening of blood donations for hepatitis C virus antibody.
June 1990, The Medical journal of Australia,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Is dual testing for hepatitis C necessary? Modelling the risk of removing hepatitis C antibody testing for Australian blood donations.
June 2023, Vox sanguinis,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Screening blood donations for hepatitis C virus by polymerase chain reaction.
January 2000, Vox sanguinis,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Hepatitis C--screening of blood donations.
June 1991, Irish medical journal,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Removing hepatitis C antibody testing for Australian blood donations: A cost-effectiveness analysis.
June 2023, Vox sanguinis,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.
June 2009, Transfusion,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Testing of blood donations for non-A, non-B hepatitis.
August 1987, Lancet (London, England),
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
June 2006, Saudi medical journal,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Estimating window period blood donations for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern Pakistan.
June 2014, Transfusion,
B C Dow, and E A Follett, and T Jordan, and F McOmish, and J Davidson, and J Gillon, and P L Yap, and P Simmonds
Detection of hepatitis C virus and human immunodeficiency virus-1 antibody-negative donations: Canadian Blood Services' experience with nucleic acid testing.
April 2006, Vox sanguinis,
Copied contents to your clipboard!